BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18677216)

  • 1. Scintigraphic assessment of recurrent glioma with focus on proliferation.
    Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
    Nucl Med Commun; 2008 Sep; 29(9):840-1. PubMed ID: 18677216
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination between glioma recurrence and radiation-induced necrosis: in regards to Qing-Shi et al. (Int J Radiat Oncol Biol Phys 2007;68:151-158).
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1585-6; author reply 1586. PubMed ID: 17674998
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.
    Vos MJ; Tony BN; Hoekstra OS; Postma TJ; Heimans JJ; Hooft L
    Nucl Med Commun; 2007 Jun; 28(6):431-9. PubMed ID: 17460533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
    Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
    J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
    Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
    Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-Tetrofosmin brain SPECT in prognostic assessment of high-grade gliomas.
    Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
    Radiother Oncol; 2008 Feb; 86(2):290. PubMed ID: 18207267
    [No Abstract]   [Full Text] [Related]  

  • 7. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
    Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
    J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1571-2. PubMed ID: 18491087
    [No Abstract]   [Full Text] [Related]  

  • 9. 99mTc-tetrofosmin SPECT for glioma evaluation.
    Alexiou GA; Tsiouris S; Kyritsis AP; Voulgaris S; Polyzoidis KS; Fotopoulos AD
    Mol Imaging Biol; 2009; 11(4):223. PubMed ID: 19326176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
    Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
    No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.
    Caresia AP; Castell-Conesa J; Negre M; Mestre A; Cuberas G; MaƱes A; Maldonado X
    Clin Transl Oncol; 2006 Oct; 8(10):750-4. PubMed ID: 17074674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Differentiation of tumour recurrence from radiation necrosis in high-grade gliomas using (201)Tl-SPECT".
    Alexiou GA; Voulgaris S; Polyzoidis K; Fotopoulos AD; Tsiouris S; Kyritsis AP
    J Clin Neurosci; 2009 Aug; 16(8):1112. PubMed ID: 19477130
    [No Abstract]   [Full Text] [Related]  

  • 13. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence.
    Black KL; Emerick T; Hoh C; Hawkins RA; Mazziotta J; Becker DP
    Neurol Res; 1994 Apr; 16(2):93-6. PubMed ID: 7914007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.
    Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
    J Neurooncol; 2011 Sep; 104(2):611. PubMed ID: 21188468
    [No Abstract]   [Full Text] [Related]  

  • 15. In Reference to Alexiou et al. (Neuro-Oncology 2008;10:104-105). Evaluation of glioma proliferation by 99mTc-Tetrofosmin.
    Beauchesne P
    Neuro Oncol; 2008 Aug; 10(4):643. PubMed ID: 18577563
    [No Abstract]   [Full Text] [Related]  

  • 16. Thallium-201 SPECT in the evaluation of gliomas.
    Tonami N
    J Nucl Med; 1993 Dec; 34(12):2089-90. PubMed ID: 8254392
    [No Abstract]   [Full Text] [Related]  

  • 17. Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma.
    Park CH; Kim SM; Zhang JJ; Intenzo CM; McEwan JR
    Clin Nucl Med; 1994 Jan; 19(1):57-8. PubMed ID: 8137586
    [No Abstract]   [Full Text] [Related]  

  • 18. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Growth patterns of recurrent tumors].
    Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
    Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1073-80. PubMed ID: 2466210
    [No Abstract]   [Full Text] [Related]  

  • 19. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
    Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
    Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
    Derlon JM
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):854-7. PubMed ID: 11677408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.